title: Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B.
abstract: BACKGROUND
  Early prophylactic thyroidectomy in patients with multiple endocrine neoplasia (MEN) type 2 offers the best chance for a normal life expectancy.
  
  
  OBJECTIVE
  To analyze the results of thyroidectomy performed during the first year of life in six patients with MEN 2A (codon 634) or MEN 2B (codon 918) syndrome.
  
  
  METHODS
  A university hospital-based prospective study from 2001 to 2008.
  
  
  METHODS
  Six family members affected either by MEN 2A (n=3) or MEN 2B (n=3) syndrome were identified through neonatal genetic screening.
  
  
  RESULTS
  Total thyroidectomy was performed at a median age of 0.8 year in the six patients, with central lymph node dissection in five. Bilateral millimetric medullary thyroid carcinoma (MTC) was found in all patients, with a unilateral lymph node micrometastasis in two of the three MEN 2B patients. Before thyroidectomy, MEN 2B patients had much higher basal serum calcitonin levels than those with MEN 2A and controls. After thyroidectomy, with a median follow-up of 3.3 years, the six patients had no evidence of persistent MTC.
  
  
  CONCLUSIONS
  Bilateral millimetric MTC may be present during the first year of life in these patients, with lymph node metastases also occurring in MEN 2B patients. These results support a total thyroidectomy at the age of about one year in MEN 2A (codon 634) children with an abnormal serum calcitonin level, and a total thyroidectomy with central neck dissection within the first weeks of life in MEN 2B patients.
authors.affiliation: Paediatric Endocrinology Department, Centre de Référence Maladies Endocriniennes Rares de la Croissance Paediatric Surgery Department Pathology, Assistance Publique-Hôpitaux de Paris, Robert Debré Hospital, 75019 Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: Zenaty
authors.forename: Y
authors.initials: Y
authors.lastname: Aigrain
authors.forename: M
authors.initials: M
authors.lastname: Peuchmaur
authors.forename: P
authors.initials: P
authors.lastname: Philippe-Chomette
authors.forename: C
authors.initials: C
authors.lastname: Baumann
authors.forename: F
authors.initials: F
authors.lastname: Cornelis
authors.forename: J P
authors.initials: JP
authors.lastname: Hugot
authors.forename: D
authors.initials: D
authors.lastname: Chevenne
authors.forename: V
authors.initials: V
authors.lastname: Barbu
authors.forename: P J
authors.initials: PJ
authors.lastname: Guillausseau
authors.forename: M
authors.initials: M
authors.lastname: Schlumberger
authors.forename: J C
authors.initials: JC
authors.lastname: Carel
authors.forename: J P
authors.initials: JP
authors.lastname: Travagli
authors.forename: J
authors.initials: J
authors.lastname: Léger
mesh_terms: D018276:Carcinoma, Medullary / Q000150:complications / Q000175:diagnosis* / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D003062:Codon / Q000235:genetics; D005190:Family; D005260:Female; D005500:Follow-Up Studies; D005820:Genetic Testing; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D018813:Multiple Endocrine Neoplasia Type 2a / Q000150:complications* / Q000175:diagnosis / Q000235:genetics; D018814:Multiple Endocrine Neoplasia Type 2b / Q000150:complications* / Q000175:diagnosis / Q000235:genetics; D015997:Neonatal Screening; D013964:Thyroid Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000601:surgery; D013965:Thyroidectomy
chemical_list: D003062:Codon